References
- Almekinders LC. Tendinitis and other chronic tendinopathies. J Am Acad Orthop Surg 1998;6:157–64.
- Sheon RP, Moskowitz RW, Goldberg VM. Soft tissue rheumatic pain. 3. ed., Baltimore, MD, USA, Williams and Wilkins 1996.
- Weiser HJ. Semimembranous insertion syndrome: a treatable and frequent cause of medial knee pain. Arch Phys Med Rehabil 1979;60:31 7–9.
- Adebajo AO, Nash P, Hazleman BL. A prospective double blind dummy placebo controlled study comparing trianicinolone hexacetonide injection with oral diclofenac 50mg TDS in patients with rotator cuff tendinitis. J Rheumatol 1990;17:120 7–10.
- Assendelft WJ, Hay EM, Adshead R, Bouter LM. Corticos-teroid injection for lateral epicondylitis: a systemic overview. Br J Gen Pract 1996;46:209–16.
- Hollingworth GR, Ellis RM, Hattersley TM. Comparison of injection technique for shoulder pain: results of a double blind randomized study. Brit Med J 1983;287:1339–41.
- Dacre JE, Beeney N, Scott DL. Injection and physiotherapy for the painful stiff shoulder. Ann Rheum Dis 1989;48:322–5.
- Stahl S, Kaufman T. The efficacy of an injection of steroids for medial epicondylitis. A prospective study of sixty elbows. J Bone Joint Surg Am 1997;79:1648–52.
- Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R, Bouter LM. Corticosteroid injection for lateral epicondylitis: a systematic review. Pain 2002;96:23–40.
- Axchrod L. Steroids. In: WN Kelly, ED Harris jr. S. Ruddy, CD Sledge eds. Textbook of rheumatology. Philadelphia, London, Torronto; Saunders Comp 1981:822–35.
- Mailer W, Stratz T, Schochat T, Mennet P. Die Therapie der Fibromyalgie mit 5-HT3-Rezeptor-Antagonisten. Z Rheuma-tol 1994;53 Suppl 1:24.
- Stratz T, Schochat T, Hrycaj P, Lacki J, Farber L, Schweiger CH, et al. Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren. Z Rheumatol 1994;53:33 5–8.
- Farber L, Stratz T, Muller W. New aspects for the medical treatment of fibromyalgia. Results of a double blind, rando-mized, placebo-controlled multi-centre trial evaluating the efficacy and tolerability of the 5-HT3-antagonist tropisetron in primary fibromyalgia. Z Rheumatol 1998;57 Suppl. 1:30.
- Farber L, Stratz T, Brückle W, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheu-matol 2000;29 Suppl 113:49–54.
- Stratz T, Mailer W. The use of 5-HT3-receptor-antagonists in various rheumatic diseases - a clue to the mechanism of action of these agents in fibromyalgia. Scand J Rheumatol 2000;29 Suppl. 113:66–71.
- Stratz T, Varga B, Muller W. Treatment of tendinopathies with tropisetron. Rheumatol Int (in press).
- Caileiet R, ed. Soft tissue pain and disability. Ed. 3, Philadelphia, Davis Comp 1996.
- Kokemohr H. Praxis der therapeutischen Lokalandsthesie und Neuraltherapie. Berlin, Heidelberg, New York, Springer 2000.
- Gordon JL. Platelets and inflammation. In: WN Kelly, ED Harris jr, S. Ruddy, CD Sledge eds. Textbook of rheu-matology. Philadelphia, London, Toronto; Saunders Comp 1981:163–78.
- Richardson BP, Engel G, Donatsch P, Stadler PA. Identifica-tion of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985;316:126–31.
- Giordano J, Rogers LV. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 1989;170:83–6.
- Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998;354:1 3–4.
- Greenshaw AJ, Silverstone PH. The non-anti-emetic uses of serotonin 5-HT3-receptor-antagonists. Drug 1997;55:2 0–30.
- Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blind study. Anesth Analg 1999;89:19 7–9.
- Ali Z, Wu G, Kozlov A, Barasi S. The role of 5-HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996;208:20 3 — 7.
- Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective antagonist. Neurosci Lett 1988; 95:313 —7.
- Saria A, Javorsky F, Humpel C, Gamse R. 5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1990;1:104–6.